Type 2 diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Control group: Individuals in the control group will not receive the transdiagnostic treatment. They will receive their usual services. However, due to professional ethics, a 4-hour in
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: having type 2 diabetes Having symptoms of emotional disorders based on a structured diagnostic interview, as well as scores obtained in Beck's Depression and Anxiety Questionnaires (scoring above 20 in depression or above 16 in the anxiety scale) participants' willingness to take part in the research based on the provisions of a written consent form.
Exclusion criteria
Exclusion criteria: Receiving a similar psychological intervention prior to the start of the intervention Medication treatment for psychological symptoms during the month prior to the start of the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in the Beck Depression Inventory. Timepoint: Assessment of depression score before intervention, last session of intervention, and 30 days after the end of intervention. Method of measurement: Measuring depression with the Beck Depression Inventory.;Anxiety score in the Beck Anxiety Inventory. Timepoint: Assessment of anxiety score before intervention, last session of intervention, and 30 days after the end of intervention. Method of measurement: Assessment of anxiety with the Beck Anxiety Inventory.;Quality of life score in the Diabetic Patients Quality of Life Inventory. Timepoint: Assessment of Quality of life score before the intervention, last session of the intervention, and 30 days after the end of the intervention. Method of measurement: Assessment of Quality of life using the Quality of Life questionnaire for diabetic patients.;Medication adherence score in the Morisky Medication Adherence Inventory. Timepoint: Assessment of medication adherence before the intervention, the last session of the intervention, and 30 days after the end of the intervention. Method of measurement: Assessment of medication adherence with the Morisky Medication Adherence Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasim Nateghi Vaighan
University of social welfare and rehabilitation sciences
Outcome results
None listed